2023
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management
Wei B, Fox L, Kaffenberger B, Korman A, Micheletti R, Mostaghimi A, Noe M, Rosenbach M, Shinkai K, Kwah J, Phillips E, Bolognia J, Damsky W, Nelson C. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management. Journal Of The American Academy Of Dermatology 2023, 90: 911-926. PMID: 37516356, DOI: 10.1016/j.jaad.2023.02.073.Peer-Reviewed Original ResearchSevere cutaneous adverse reactionsCutaneous adverse reactionsSystemic symptomsDrug reactionsAdverse reactionsDifferential diagnosisDrug-induced hypersensitivity syndrome/drug reactionDrug-induced hypersensitivity syndromeDiHS/DRESSVisceral organ involvementSteroid-sparing agentCornerstone of managementFirst-line therapyEvidence-based overviewSystemic corticosteroidsHypersensitivity syndromeImmediate discontinuationOrgan involvementRisk stratificationAutoimmune diseasesAdjunctive testNeoplastic disordersDiagnostic criteriaLongitudinal evaluationDiagnosisDrug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis
Wei B, Fox L, Kaffenberger B, Korman A, Micheletti R, Mostaghimi A, Noe M, Rosenbach M, Shinkai K, Kwah J, Phillips E, Bolognia J, Damsky W, Nelson C. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis. Journal Of The American Academy Of Dermatology 2023, 90: 885-908. PMID: 37516359, DOI: 10.1016/j.jaad.2023.02.072.Peer-Reviewed Original ResearchSevere cutaneous adverse reactionsDiHS/DRESSClinicopathological featuresSystemic symptomsDrug reactionsDrug-induced hypersensitivity syndrome/drug reactionDrug-induced hypersensitivity syndromePart I. EpidemiologyVisceral organ involvementCutaneous adverse reactionsRisk of relapseHypersensitivity syndromeOrgan involvementI. EpidemiologyOrgan dysfunctionSignificant morbidityAutoimmune diseasesAdverse reactionsDrug exposureT cellsCommon triggerImmune systemPathogenesisEosinophiliaMedical education activitiesEarly Detection and Prognostic Assessment of Cutaneous Melanoma
Kashani-Sabet M, Leachman S, Stein J, Arbiser J, Berry E, Celebi J, Curiel-Lewandrowski C, Ferris L, Grant-Kels J, Grossman D, Kulkarni R, Marchetti M, Nelson K, Polsky D, Seiverling E, Swetter S, Tsao H, Verdieck-Devlaeminck A, Wei M, Bar A, Bartlett E, Bolognia J, Bowles T, B. K, Chu E, Hartman R, Hawryluk E, Jampel R, Karapetyan L, Kheterpal M, Lawson D, Leming P, Liebman T, Ming M, Sahni D, Savory S, Shaikh S, Sober A, Sondak V, Spaccarelli N, Usatine R, Venna S, Kirkwood J. Early Detection and Prognostic Assessment of Cutaneous Melanoma. JAMA Dermatology 2023, 159: 545-553. PMID: 36920356, PMCID: PMC11225588, DOI: 10.1001/jamadermatol.2023.0127.Peer-Reviewed Original ResearchConceptsRisk-stratified approachCutaneous melanomaGEP scorePrognostic assessmentGene expression profile testingMelanoma screeningEarly detectionLow-risk histologyNegative nodal statusDelphi consensus methodReflectance confocal microscopyNodal statusSentinel lymphAdvanced melanomaHistologic featuresScreening eventsScreening practicesConsensus statementConsensus recommendationsSkin lesionsDermoscopic examinationGEP testingConsensus conferenceMelanocytic skin lesionsClinical setting33 Lupus érythémateux
Bolognia J, Schaffer J, Duncan K, Ko C. 33 Lupus érythémateux. 2023, 303-315. DOI: 10.1016/b978-2-294-77853-7.00033-0.Peer-Reviewed Original Research81 Hypertrophies dermiques
Bolognia J, Schaffer J, Duncan K, Ko C. 81 Hypertrophies dermiques. 2023, 824-826. DOI: 10.1016/b978-2-294-77853-7.00081-0.Peer-Reviewed Original Research98 Lymphomes cutanés à cellulesT
Bolognia J, Schaffer J, Duncan K, Ko C. 98 Lymphomes cutanés à cellulesT. 2023, 1001-1016. DOI: 10.1016/b978-2-294-77853-7.00098-6.Peer-Reviewed Original Research21 Dermatoses neutrophiliques
Bolognia J, Schaffer J, Duncan K, Ko C. 21 Dermatoses neutrophiliques. 2023, 211-220. DOI: 10.1016/b978-2-294-77853-7.00021-4.Peer-Reviewed Original Research88 Kératose actinique, carcinome basocellulaire etcarcinome spinocellulaire
Bolognia J, Schaffer J, Duncan K, Ko C. 88 Kératose actinique, carcinome basocellulaire etcarcinome spinocellulaire. 2023, 895-910. DOI: 10.1016/b978-2-294-77853-7.00088-3.Peer-Reviewed Original Research63 Rickettsioses
Bolognia J, Schaffer J, Duncan K, Ko C. 63 Rickettsioses. 2023, 631-639. DOI: 10.1016/b978-2-294-77853-7.00063-9.Peer-Reviewed Original Research97 Lymphomes cutanés àcellulesB
Bolognia J, Schaffer J, Duncan K, Ko C. 97 Lymphomes cutanés àcellulesB. 2023, 993-1000. DOI: 10.1016/b978-2-294-77853-7.00097-4.Peer-Reviewed Original Research24 Pemphigoïde bulleuse, pemphigoïde muqueuse etépidermolyse bulleuse acquise
Bolognia J, Schaffer J, Duncan K, Ko C. 24 Pemphigoïde bulleuse, pemphigoïde muqueuse etépidermolyse bulleuse acquise. 2023, 235-240. DOI: 10.1016/b978-2-294-77853-7.00024-x.Peer-Reviewed Original Research76 Histiocytoses
Bolognia J, Schaffer J, Duncan K, Ko C. 76 Histiocytoses. 2023, 789-794. DOI: 10.1016/b978-2-294-77853-7.00076-7.Peer-Reviewed Original Research44 Maladie du greffon contre l'hôte
Bolognia J, Schaffer J, Duncan K, Ko C. 44 Maladie du greffon contre l'hôte. 2023, 396-402. DOI: 10.1016/b978-2-294-77853-7.00044-5.Peer-Reviewed Original Research2 Diagnostics au lit du malade
Bolognia J, Schaffer J, Duncan K, Ko C. 2 Diagnostics au lit du malade. 2023, 21-28. DOI: 10.1016/b978-2-294-77853-7.00002-0.Peer-Reviewed Original Research53 Anomalies du développement
Bolognia J, Schaffer J, Duncan K, Ko C. 53 Anomalies du développement. 2023, 489-502. DOI: 10.1016/b978-2-294-77853-7.00053-6.Peer-Reviewed Original Research71 Infestations
Bolognia J, Schaffer J, Duncan K, Ko C. 71 Infestations. 2023, 733-741. DOI: 10.1016/b978-2-294-77853-7.00071-8.Peer-Reviewed Original Research90 Kystes
Bolognia J, Schaffer J, Duncan K, Ko C. 90 Kystes. 2023, 917-921. DOI: 10.1016/b978-2-294-77853-7.00090-1.Peer-Reviewed Original Research23 Pemphigus
Bolognia J, Schaffer J, Duncan K, Ko C. 23 Pemphigus. 2023, 228-234. DOI: 10.1016/b978-2-294-77853-7.00023-8.Peer-Reviewed Original Research70 Protozoaires et vers
Bolognia J, Schaffer J, Duncan K, Ko C. 70 Protozoaires et vers. 2023, 723-732. DOI: 10.1016/b978-2-294-77853-7.00070-6.Peer-Reviewed Original Research26 Épidermolyses bulleuses
Bolognia J, Schaffer J, Duncan K, Ko C. 26 Épidermolyses bulleuses. 2023, 247-253. DOI: 10.1016/b978-2-294-77853-7.00026-3.Peer-Reviewed Original Research